Navigation Links
VIDEO from Endo Pharmaceuticals Available on FDA Approves New Treatment for Low Testosterone

NEW YORK, Jan. 3, 2011 /PRNewswire/ -- See video from Endo Pharmaceuticals at:  

The FDA has approved Fortesta™ (testosterone) gel for the treatment of adult males with low testosterone or "Low T," a condition that affects nearly 14 million men in the United States. Available content includes an audio news release, b-roll and soundbites.

About delivers free broadcast- and streaming-quality video and multimedia content directly to media around the world, 24/7. More than 25,000 media outlets in 190+ countries use, including the AP, BBC, CNBC, CNN, France 24, N24,, RAI, TVE, ZDF and a lot more.  

Registered journalists can preview and download video, audio, text, graphics and photos at

If not already registered, please take a moment to sign up - registration is quick, easy and free:

We are always happy to receive your feedback, suggestions or enquiries. Email us at

Story Id: 21143

Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. VIDEO From Siemens and Synaptic Digital: Not Your Fathers X-Ray Machine
2. VIDEO from Siemens Corporation Available on Amazing Medical Images: Diagnosing in the Digital Age
3. Guardian 24/7 Offers Remote High-Touch Health Care via Glowpoint Video Managed Services
4. Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011
5. Access Pharmaceuticals Updates MuGard Website With First Patient Testimonial Video
6. VIDEO from Merck and Co., Inc available on In Phase III Study Mercks Investigational CETP Inhibitor Anacetrapib Met Safety and Efficacy Endpoints in Patients with CHD
7. VIDEO from International Osteoporosis Foundation available on IOF Focuses on WHO Fracture Risk Assessment Tool for International Discussions
8. Shrink Nanotechnologies Unveils Videos of StemDisc450 Prototype Growing Human Embryonic Stem Cells
9. VIDEO From and Lundbeck: Lundbeck Continues Strong Growth in Third Quarter
10. VIDEO from and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
11. VIDEO from and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
Post Your Comments:
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
Breaking Medicine News(10 mins):